These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 36115967)

  • 1. Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation.
    Arighi A; Arcaro M; Fumagalli GG; Carandini T; Pietroboni AM; Sacchi L; Fenoglio C; Serpente M; Sorrentino F; Isgrò G; Turkheimer F; Scarpini E; Galimberti D
    Alzheimers Res Ther; 2022 Sep; 14(1):135. PubMed ID: 36115967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?
    Arighi A; Di Cristofori A; Fenoglio C; Borsa S; D'Anca M; Fumagalli GG; Locatelli M; Carrabba G; Pietroboni AM; Ghezzi L; Carandini T; Colombi A; Scarioni M; De Riz MA; Serpente M; Rampini PM; Scarpini E; Galimberti D
    J Alzheimers Dis; 2019; 69(3):663-669. PubMed ID: 31156164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "glympse" into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin-4 for the assessment of glymphatic system in Alzheimer's disease and other dementias.
    Sacchi L; D'Agata F; Campisi C; Arcaro M; Carandini T; Örzsik B; Dal Maschio VP; Fenoglio C; Pietroboni AM; Ghezzi L; Serpente M; Pintus M; Conte G; Triulzi F; Lopiano L; Galimberti D; Cercignani M; Bozzali M; Arighi A
    Hum Brain Mapp; 2024 Aug; 45(12):e26805. PubMed ID: 39185685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glymphatic function and clearance of tau in an Alzheimer's disease model.
    Harrison IF; Ismail O; Machhada A; Colgan N; Ohene Y; Nahavandi P; Ahmed Z; Fisher A; Meftah S; Murray TK; Ottersen OP; Nagelhus EA; O'Neill MJ; Wells JA; Lythgoe MF
    Brain; 2020 Aug; 143(8):2576-2593. PubMed ID: 32705145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid β plaque formation in mice.
    Simon M; Wang MX; Ismail O; Braun M; Schindler AG; Reemmer J; Wang Z; Haveliwala MA; O'Boyle RP; Han WY; Roese N; Grafe M; Woltjer R; Boison D; Iliff JJ
    Alzheimers Res Ther; 2022 Apr; 14(1):59. PubMed ID: 35473943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
    Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration.
    Ishida K; Yamada K; Nishiyama R; Hashimoto T; Nishida I; Abe Y; Yasui M; Iwatsubo T
    J Exp Med; 2022 Mar; 219(3):. PubMed ID: 35212707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Glymphatic Outflow of Tau from Brain to Cerebrospinal Fluid in Mice.
    Ishida K; Yamada K
    Methods Mol Biol; 2024; 2754():351-359. PubMed ID: 38512676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
    Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
    J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus.
    Reeves BC; Karimy JK; Kundishora AJ; Mestre H; Cerci HM; Matouk C; Alper SL; Lundgaard I; Nedergaard M; Kahle KT
    Trends Mol Med; 2020 Mar; 26(3):285-295. PubMed ID: 31959516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endostatin level in cerebrospinal fluid of patients with Alzheimer's disease.
    Salza R; Oudart JB; Ramont L; Maquart FX; Bakchine S; Thoannès H; Ricard-Blum S
    J Alzheimers Dis; 2015; 44(4):1253-61. PubMed ID: 25408220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.
    Boespflug EL; Simon MJ; Leonard E; Grafe M; Woltjer R; Silbert LC; Kaye JA; Iliff JJ
    J Alzheimers Dis; 2018; 66(4):1587-1597. PubMed ID: 30475760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.
    Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Boulanghien J; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Perret-Liaudet A; Touchon J; Lehmann S
    J Alzheimers Dis; 2011; 26(3):553-63. PubMed ID: 21709372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astroglial water channel aquaporin 4-mediated glymphatic clearance function: A determined factor for time-sensitive treatment of aerobic exercise in patients with Alzheimer's disease.
    Yin M; Pu T; Wang L; Marshall C; Wu T; Xiao M
    Med Hypotheses; 2018 Oct; 119():18-21. PubMed ID: 30122483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.
    Boström G; Freyhult E; Virhammar J; Alcolea D; Tumani H; Otto M; Brundin RM; Kilander L; Löwenmark M; Giedraitis V; Lleó A; von Arnim CAF; Kultima K; Ingelsson M
    J Alzheimers Dis; 2021; 81(2):629-640. PubMed ID: 33814444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
    Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
    Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid tau, p-tau 181 and amyloid-β38/40/42 in frontotemporal dementias and primary progressive aphasias.
    Bibl M; Mollenhauer B; Lewczuk P; Esselmann H; Wolf S; Otto M; Kornhuber J; Rüther E; Wiltfang J
    Dement Geriatr Cogn Disord; 2011; 31(1):37-44. PubMed ID: 21135556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia.
    Landqvist Waldö M; Frizell Santillo A; Passant U; Zetterberg H; Rosengren L; Nilsson C; Englund E
    BMC Neurol; 2013 May; 13():54. PubMed ID: 23718879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.